Medilayse Company

We face a global crisis of care regarding our current and projected capacity to provide high-quality long-term care to frail elders and their families [1]. As life expectancy continue to raise, millions of elderly’s struggle every day with health and safety challenges [2]. Our value-based multidisciplinary technology improves the quality of geriatric care , improves patient safety, all by elevating the financial value of transparency at long term care facilities. The novelty of our technology comes down to our elegant yet simple to implement algorithmic engine. Our cloud-based software (SASS) uses advanced cloud computing tools (classification, association analysis, clustering) combined with evidence based models ('severity of illness'' ''frailty index'' ) on smart raw data (driven from various IOT monitoring technologies) , providing ''on-spot'' actionable information regarding patient quality of care (continuity of care & patient scheduling ) and patient safety (Early Warning Signs for phycological and mental deterioration ) , all of which is summarized as one easy to follow numeric indicator (patent pending). Whether you're a shareholder at a long term care facility, a medical personnel at long term care facility or a family member of a nursing home resident, you can be rest assured that our technology will meet your needs. [1] Nord J Nurs, Author manuscript; PMC 2017 [2] National Council on Aging
Technology: Treatment Programs
Industry: NeuroTech
Headquarters: Asia
Founded Date: 2016-03-22
Employees Number: 1-10

info@medilayse.me
Register and Claim Ownership